Ask the Doctors June 2016 Issue

Ask the Doctors: June 2016

Michael Rocco, MD, medical director of Cardiac Rehabilitation and Stress Testing at Cleveland Clinic.

Ask the Doctors: June 2016

It is important to recognize a few things about these drugs. They have been shown to consistently lower LDL cholesterol by over 50 percent with good tolerance. However, studies to examine long-term safety and ability to reduce adverse heart and vascular events are still ongoing. Due to the absence of clinical trials demonstrating long-term benefit they are approved only for use in certain high-risk patients. Lastly, the drugs are expensive, costing up to $14,000 a year.

To continue reading this article you must be a paid subscriber.

Subscribe to Heart Advisor

Get the next year of HEART ADVISOR for just $20. That's a savings of $19 off the regular rate.

With your paid subscription you will receive unlimited access to all of our online content. That is over a decade of previous issues from Cleveland Clinic, the hospital rated #1 in cardiac care by U.S. News & World Report - free of charge.

Subscriber Log In

Forgot your password? Click Here.

Already subscribe but haven't registered for all the benefits of the website? Click here.